jRCT2031250105招募中不适用
A Phase IIb, double-masked, randomized, multi-center, placebo-controlled, parallel-group study of STN1014100 ophthalmic solution in patients with dry eye
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 400
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •18 years of age or older
- •Male or Female
- •Both eyes diagnosed with dry eye
排除标准
- •Any corneal and conjunctival abnormalities or other diseases other than dry eye affecting the ocular surface
- •Having any eye disease requiring treatment other than dry eye.
- •Anatomically and functionally abnormal eyelids (e.g. Eyelid closure failure)
- •The principal investigator or a sub-investigator judges it inappropriate as the subject of this clinical trial.
结局指标
主要结局
-
Change from baseline in dry eye signs
次要结局
未报告次要终点
研究者
相似试验
招募中
1 期
A phase I/IIa study of STN1014100 ophthalmic solution in healthy adult male volunteers and dry eye patientsDry eyeJPRN-jRCT2051220152Koji Oka134
已完成
1 期
A phase I study of STN1013400 ophthalmic solution in healthy adult male volunteerMyopiaJPRN-jRCT2031210208Migita Yukie48
已完成
1 期
A phase I study of STN1013600 ophthalmic solution in healthy adult male volunteerPresbyopiaJPRN-jRCT2031210614Migita Yukie24
已完成
2 期
Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With PresbyopiaPresbyopiaNCT05665387Santen Inc.79
已完成
2 期
A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)Fuchs Endothelial Corneal DystrophyNCT05376176Santen Inc.86